The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

Affiliations

• ¹ Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Düsseldorf, Germany. [email protected].
• ² Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Düsseldorf, Germany.
• ³ Department of Hematology and Medical Oncology, Georg August University, Göttingen, Germany.
• ⁴ Institute of Human Genetics, Heinrich Heine University, Düsseldorf, Germany.
• ⁵ Department of Hematology, Oncology and Palliative Care, Marien Hospital, Duesseldorf, Germany.
• ⁶ Department of Hematology, Oncology and Clinical Immunology, Johannes Hospital, Duisburg, Germany.
• ⁷ Centre Hospitalier Universitaire Vaudois, Service d'hématologie, Département d'oncologie, and Lausanne University (UNIL), Lausanne, Switzerland.
• ⁸ Department of Hematology and Oncology, University Hospital, Mannheim, Germany.
• ⁹ Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria.
• ¹⁰ Ludwig Boltzmann Institute for Hematology and Oncology, Hanusch Hospital and Medical University of Vienna, Vienna, Austria.
• ¹¹ Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
• ¹² Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany.
• ¹³ Institute of Pathology, Heinrich Heine University, Düsseldorf, Germany.
• ¹⁴ Department of Internal Medicine, Medical University, Innsbruck, Austria.
• ¹⁵ Elisabethinen Hospital, Linz, Austria.
• ¹⁶ Department of Medicine III, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.